Folate and cobalamin modify associations between S-adenosylmethionine and methylated arsenic metabolites in arsenic-exposed bangladeshi adults1-3

Journal of Nutrition

Volumn 144, Issue 5, 2014, Pages 690-697

  Howe, Caitlin G ^a   Niedzwiecki, Megan M ^a   Hall, Megan N ^a   Liu, Xinhua ^a   Ilievski, Vesna ^a   Slavkovich, Vesna ^a   Alam, Shafiul ^b   Siddique, Abu B ^b   Graziano, Joseph H ^a   Gamble, Mary V ^a  

^a Department of Environmental Health Sciences Mailman School of Public Health Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; COBALAMIN; FOLIC ACID; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ADULT; ARTICLE; BANGLADESH; BLOOD ANALYSIS; CARBON METABOLISM; CHEMICAL MODIFICATION; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; METHYLATION; NUTRITIONAL STATUS; OXIDATIVE STRESS; URINE;

ADULT; AGED; ARSENIC; ARSENIC POISONING; ARSENICALS; BANGLADESH; CROSS-SECTIONAL STUDIES; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; METHYLATION; MIDDLE AGED; OXIDATIVE STRESS; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; VITAMIN B 12;

EID: 84898863009     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.188789     Document Type: Article

References (55)

1. Bagchi S. Arsenic threat reaching global dimensions. CMAJ. 2007;177: 1344-5.
2. Smith AH, Lingas E, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78:1093-103.
3. Kinniburgh D, Smedley PL, Davies J, Milne CJ, Gaus I, Trafford JM, Burden S, Ihtisha-mul Huq SM, Ahmad N, Ahmed KM. The scale and causes of the groundwater arsenic problem in Bangladesh. In: Arsenic in ground water: geochemistry and occurrence. Editors:Welch AH, Stollenwerk KG. Boston: Kluwer Academic Publishers: 2003. p. 211-57.
4. World Bank. 2005. Towards a more effective operational response: arsenic contamination of groundwater in south and east asian countries. Vol. 1: Policy Report No. 31303.
5. Brown KG, Boyle KE, Chen CW, Gibb HJ. A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal. 1989;9:519-28.
6. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol. 1998;27:561-9.
7. Chiou H-Y, Hsueh Y-M, Liaw K-F, Horng S-F, Chiang M-H, Pu Y-S, Lin JS-N, Huang C-H, Chen C-J. Incidence of internal cancers and ingested inorganic arsenic: a seven year follow-up study in Taiwan. Cancer Res. 1995;55:1296-300.
8. Hertz-Picciotto I, Smith AH. Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health. 1993;19:217-26.
9. Tseng C-H, Huang, Y-K, Huang Y-L, Chung C-J, Yang M-H, Chen C-J, Hsueh Y-M. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in Blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol. 2005;206:299-308.
10. WuMM, Chiou HY, Hsueh YM, Hong CT, Su CL, Chang SF, HuangWL, Wang HT, Wang YH, Hsieh YC, et al. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol Appl Pharmacol. 2006;216:168-75.
11. Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM. Arsenic methylation capability and hypertension risk in subjects living in arseniasishyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol. 2007;218:135-42.
12. Hafeman DM, Ahsan H, Louis ED, Siddique AB, Slavkovich V, Cheng Z, van Geen A, Graziano JH. Association between arsenic exposure and a measure of subclinical sensory neuropathy in Bangladesh. J Occup Environ Med. 2005;47:778-84.
13. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, Loiacono NJ, Cheng Z, Hussain I, et al. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 2004;112:1329-33.
14. Vahter M. Mechanisms of arsenic biotransformation. Toxicology. 2002;181-182:211-7.
15. Steinmaus C, Yuan Y, Kalman D, Rey OA, Skibola CF, Dauphine D, Basu A, Porter KE, Hubbard A, Bates MN, Smith MT, Smith AH. Individual differences in arsenic metabolism and lung cancer in a casecontrol study in Cordoba, Argentina. Toxicol Appl Pharmacol. 2010;247:138-45.
16. Buchet JP. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch Toxicol. 1985;57:125-9.
17. Finkelstein J, Kyle KE, Harris BJ. Methionine metabolism in mammals: regulatory effects of S-adenosylhomocysteine. Arch Biochem Biophys. 1974;165:744-8.
18. Eloranta TO, Kajander EO, Raina AM. A new method for the assay of tissue S-adenosylhomocysteine and S-adenosylmethionine. Biochem J. 1976;160:287-94.
19. De Kimpe J, Cornelis R, Vanholder R. In vitro methylation of arsenite by rabbit liver cytosol: effect of metal ions, metal chelating agents, methyltransferase inhibitors and uremic toxins. Drug Chem Toxicol. 1999;22:613-28.
20. Cantoni GL. The role of S-adenosylhomocysteine in the biological utilization of S-adenosylmethionine. Prog Clin Biol Res. 1985;198:47-65.
21. Chiang PK. Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo. Biochem Pharmacol. 1979;28:1897-902.
22. Hoffman DR, Marion DW, Cornatzer WE, Duerre JA. S-adenosylmethionine and S-adenosylhomocysteine metabolism in isolated liver. J Biol Chem. 1980;255:10822-7.
23. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Chen Y, Levy D, Factor-Litvak P, et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr. 2006;84:1093-101.
24. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, Levy D, van Geen A, Howe G, Graziano J. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol. 2006;16:191-205.
25. Hall MN, Niedzwiecki M, Liu X, Harper KN, Alam S, Slavkovich V, Ilievski V, Levy D, Siddique S, Parvez F, et al. Chronic arsenic exposure and blood glutathione and glutathione disulfide concentrations in Bangladeshi adults. Environ Health Perspect. 2013;121:1068-74.
26. Harper K, Liu X, Hall MN, Ilievski V, Oka J, Calancie L, Slavkovich V, Levy D, Siddique A, Alam S, et al. A dose-response study of arsenic exposure markers of oxidative damage in Bangladesh. J Occup. Environ. Med. In press 2014.
27. Chen Y, Ahsan H, Parvez F, Howe GR. Validity of a food-frequency questionnaire for a large prospective cohort study in Bangladesh. Br J Nutr. 2004;92:851-9.
28. Cheng Z, Zheng Y, Mortlock R, Van Geen A. Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem. 2004;379:512-8.
29. Van Geen A, Cheng Z, Seddique AA, Hoque MA, Gelman A, Graziano JH, Ahsan H, Parvez F, Ahmed KM. Reliability of a commercial kit to test groundwater for arsenic in Bangladesh. Environ Sci Technol. 2005;39:299-303.
30. Hall M, Chen Y, Ahsan H, Slavkovich V, van Geen A, Parvez F, Graziano J. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology. 2006;225:225-33.
31. Nixon DE, Mussmann G, Eckdahl S, Moyer T. Total arsenic in urine: Palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem. 1991;37:1575-9.
32. Slot C. Plasma creatinine determination: a new and specific Jaffe reaction method. Scand J Clin Lab Invest. 1965;17:381-7.
33. Niedzwiecki MM, Hall MN, Liu X, Oka J, Harper KN, Slavkovich V, Ilievski V, Levy D, Van Geen A, Mey JL, et al. A dose-response study of arsenic exposure and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults. Environ Health Perspect. 2013;121:1306.
34. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82:442-50.
35. Wise CK, Cooney CA, Ali SF, Poirier LA. Measuring S-adenosylmethionine in whole blood, red blood cells and cultured cells using a fast preparation method and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997;696:145-52.
36. Christenson RH, Dent GA, Tuszynski A. Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study. Clin Chem. 1985;31:1358-60.
37. NIH. Dietary supplement fact sheet: vitamin B12. 2011 [cited 2014 Jan 26]. Available from: http://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/.
38. NIH. Dietary supplement fact sheet: folate. 2012 [cited 2014 Jan 26]. Available from: http://ods.od.nih.gov/factsheets/Folate-HealthProfessional/.
39. Buchet JP. Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem Pharmacol. 1988;37:3149-53.
40. Takahashi KYH, Mashiko M, Yamamura Y. [Effect of S-adenosylmethionine on methylation of inorganic arsenic.] Nippon Eiseigaku Zasshi. 1990;45:613-8.
41. Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Levy D, Factor-Litvak P, Graziano JH. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect. 2005;113:1683-8.
42. Song X, Geng Z, Li X, Hu X, Bian N, Zhang X, Wang Z. New insights into the mechanism of arsenite methylation with the recombinant human arsenic (+3) methyltransferase (hAS3MT). Biochimie. 2010;92:1397-406.
43. Finkelstein JD, Kyle WE, Harris BJ, Martin JJ. Methionine metabolism in mammals: concentration of metabolites in rat tissues. J Nutr. 1982;112:1011.
44. Finkelstein JD, Martin JJ. Methionine metabolism in mammals: distribution of homocysteine between competing pathways. J Biol Chem. 1984;259:9508-13.
45. Lawley SD, Cinderella M, Hall MN, Gamble MV, Nijhout HF, Reed MC. Mathematical model insights into arsenic detoxification. Theor Biol Med Model. 2011;8:31.
46. Styblo M, Del Razo LM, LeCluyse EL, Hamilton GA, Wang C, Cullen WR, Thomas DJ. Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem Res Toxicol. 1999;12:560-5.
47. Thomas DJ LJ, Waters SB, Xing W, Adair BM, Drobna Z, Devesa V, Styblo M. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med (Maywood). 2007;232:3-13.
48. Loehrer FM, Angst CP, Haefeli WE, Jordan PP, Ritz R, Fowler B. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease. Arterioscler Thromb Vasc Biol. 1996;16:727-33.
49. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80:1611-7.
50. Obeid R, Schadt A, Dillmann U, Kostopoulos P, Fassbender K, Herrmann W. Methylation status and neurodegenerative markers in Parkinson disease. Clin Chem. 2009;55:1852-60.
51. Obeid R, Hartmuth K, Hermann W, Gortner L, Rohrer TR, Geisel J, Reed MC, Nijhout HF. Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model. Mol Nutr Food Res. 2012;56:1582-9.
52. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, Santos-Guzman J, Swendseid ME, Cogger EA, James SJ. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathione beta-synthase heterozygous mice. J Nutr. 2001;131:2811-8.
53. James S, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr. 2002;132 (8):2361S-6S.
54. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000;275:29318-23.
55. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Graziano JH, Gamble MV. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect. 2009;117:254-60.